FDA Clearance Tracker · P130026-S072
TactiCath Contact Force Ablation Catheter, Sensor Enabled
Last checked: Nov 20, 2026Latest source record: Mar 4, 2022 (this decision)Source: openFDAMethods & limitations
Decided
Mar 4, 2022
Approved
Time to decision
308 days
Received Apr 30, 2021. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P130026-S072
- Device name
- TactiCath Contact Force Ablation Catheter, Sensor Enabled
- Applicant
- St Jude Medical
- Applicant location
- St. Paul, MN
- Received
- Apr 30, 2021
- Decided
- Mar 4, 2022
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P130026
Device type
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
Approval for a change to a patient-contacting adhesive material and the curing mechanism.
Source documents
Other decisions for St Jude Medical
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K223077 · Decided Dec 7, 2022 · 68 days after receipt
Device type: Catheter, Ultrasound, Intravascular (OBJ) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.